HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Y Hsueh Selected Research

Nephroureterectomy

1/2022The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study.
1/2022Is Lymph Node Dissection Necessary During Radical Nephroureterectomy for Clinically Node-Negative Upper Tract Urothelial Carcinoma? A Multi-Institutional Study.
1/2021Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy.
1/2021Comparing Oncological Outcomes and Surgical Complications of Hand-Assisted, Laparoscopic and Robotic Nephroureterectomy for Upper Tract Urothelial Carcinoma.
1/2021Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan.
11/2020Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan.
3/2007Survival analysis in patients with upper urinary tract transitional cell carcinoma: a comparison between open and hand-assisted laparoscopic nephroureterectomy.
10/2004A comparison of the clinical outcome between open and hand-assisted laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Y Hsueh Research Topics

Disease

8Carcinoma (Carcinomatosis)
02/2022 - 11/2020
7Neoplasms (Cancer)
02/2022 - 07/2016
2Transitional Cell Carcinoma
03/2007 - 10/2004
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Lymphatic Metastasis
01/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2022
1Hydronephrosis
01/2022
1Chronic Kidney Failure (Chronic Renal Failure)
01/2021
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
01/2021
1Residual Neoplasm
07/2016
1Cardiovascular Diseases (Cardiovascular Disease)
05/2014
1Inguinal Hernia (Direct Inguinal Hernia)
01/2014
1Varicocele
01/2014
1Erectile Dysfunction
06/2013
1Convalescence
10/2004
1Hemorrhage
10/2004

Drug/Important Bio-Agent (IBA)

1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
14-acetylantroquinonol BIBA
01/2022
1epimedin CIBA
05/2014
1epimedii flavoneIBA
05/2014
1Sildenafil Citrate (Viagra)FDA Link
06/2013
1Phosphodiesterase 5 InhibitorsIBA
06/2013
1Analgesics (Analgesic Drugs)IBA
10/2004

Therapy/Procedure

8Nephroureterectomy
01/2022 - 10/2004
2Adjuvant Chemotherapy
02/2022 - 01/2022
2Length of Stay
01/2021 - 10/2004
1Therapeutics
01/2022
1Drug Therapy (Chemotherapy)
01/2022
1Lymph Node Excision (Lymph Node Dissection)
01/2022
1Transurethral Resection of Bladder
07/2016
1Herniorrhaphy
01/2014
1Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2013